Oncology (Cancer) Genetics

Hereditary Cancer Screening

Istock 155444541

Why to Test Hereditary Cancer?

Hereditary Cancer Screening

Individuals with a family history of cancer may have an increased risk of cancer if they have inherited a cancercausing mutation. Different gene mutations can cause diverse types of cancer.

Hereditary cancers account for approximately 5-10% of all cancers, and people who inherit genetic mutations generally are more likely to develop certain cancers at an earlier age of onset than the common population.

With the genetic information, high-risk people can take a regular examination and preventive measures to improve health and quality of life.

Sample Requirements

Saliva: ≥2ml

peripheral blood: ≥5ml

good quality DNA: ≥3µg

What is Sentis Hereditary Cancer Panel?

Group (12)

Comprehensive

Detects 79 gene across 24 important cancers with complete database

Group (10)

Convenient

Only 5mL blood or 2mL saliva is needed for testing

Group 30586 (1)

Accurate

99.9% accuracy with alternative validation

Technology

Next-generation sequencing for the whole-exome plus flanking intronic regions covered for all genes tested; one single assay that detects point mutations, deletions, insertions, duplications, rearrangements.

Who is suitable for the test?

For patients

confirm the cause of cancer

guide treatment decisions

assess the risk of other cancers

For healthy people and relatives

assess the risk of hereditary cancers

take necessary interventions for testee and family members

TAT

Turnaround times for specific tests vary as per the table below. TATs are calculated from the time the sample is received and accepted at the laboratory.

Genalive offers the following Hereditary Cancer Panels:

Product Name Product Code TAT
Sentis™ BRCA (2 genes) SDX2001 10-15 days
Sentis™ Hereditary Breast and Ovarian Cancer (HBOC) (26 genes) SDX2002 10-15 days
Sentis™ Hereditary Cancer Panel (Female) (85 genes) SDX2003 10-15 days
Sentis™ Hereditary Cancer Panel (Male)(90 genes) SDX2004 10-15 days
Sentis™ Hereditary Pancreatic Cancer SDX2005 10-15 days
Sentis™ Hereditary Prostate Cancer SDX2006 10-15 days
Sentis™ Hereditary Colorectal Cancer SDX2006 10-15 days

Genalive Genetic Counselors are available to Healthcare providers to help navigate which test is best for their patient.

Indication for Testing

Hereditary cancer type Male package Female package
Breast
Ovarian  
Prostate  
Colorectal
Melanoma
Gastric
Endometrial  
Renal
Pancreatic
Bladder
Thyroid
Parathyroid
Multiple Endocrine Neoplasia
Neurofibromatosis
Pheochromocytoma
Familial Paraganglioma
Retinoblastoma
Chondrosarcoma
Gastrointestinal Stromal
Urothelial Carcinoma
Tuberous Sclerosis
Nephroblastoma
Neuroblastoma
Nevoid Basal Cell Carcinoma